Ayala Pharmaceuticals Inc Revenue per Employee (ADXS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ayala Pharmaceuticals Inc   (ADXS)
 

Ayala Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Ayala Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,182, but the productivity of Ayala Pharmaceuticals Inc 's employees remained above the company average.
Within the Healthcare sector Ayala Pharmaceuticals Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Ayala Pharmaceuticals Inc has 11 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADXS Revenue per Employee (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Revenue Change - - - -98.4 % -
Sales per Employee (TTM) $ 1,182 10,727 10,727 9,909 32,273
ADXS's Total Ranking # # # # #
Seq. Revenue Change - - 125 % -96.19 % -

ADXS Company Profile >> Back to ADXS Efficiency Comparisons >> Compare ADXS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 2,154,216 $ 1,067,447 $ 23,636
(Jan 31 2019)   (Apr 30 2020)



Financial Statements
Ayala Pharmaceuticals Inc 's Revenue MRQ $ 0 Millions Visit ADXS's Income Statement
Ayala Pharmaceuticals Inc 's Revenues TTM $ 0 Millions Visit ADXS's aggregate revenue growth
What are ADXS's Sales? Visit ADXS's Sales by Segment




Other Ratios
Ayala Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ADXS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ADXS's Competitors
Revenue per Employee for ADXS's Suppliers
Revenue per Employee for ADXS's Customers

You may also want to know
ADXS's Sales Growth Rates ADXS's Pe Price to earnings ratio ADXS's Receivables Turnover Ratio ADXS's Stock Quote
ADXS's Net Income Growth Rates ADXS's Ps Price to Sales ratio ADXS's Sales per Employee ADXS's Asset Turnover Ratio
ADXS's Net Margin ADXS's Pb Price to Book ratio ADXS's Financial Strength Ratios ADXS's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:19+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Evaxion A  1,622.22 $ 0.073  Million 45 
Chimerix Inc   1,611.94 $ 0.324  Million 201 
Ataibeckley Inc   1,554.46 $ 0.314  Million 202 
Check Cap Ltd  1,473.68 $ 0.056  Million 38 
Viridian Therapeutics Inc   1,246.03 $ 0.314  Million 252 
Inflarx N V  1,087.07 $ 0.071  Million 65 
Geron Corporation  918.60 $ 0.237  Million 258 
Immunitybio inc   900.14 $ 0.622  Million 691 
Axim Biotechnologies Inc   878.18 $ 0.040  Million 45 
Lyell Immunopharma Inc   807.45 $ 0.130  Million 161 
Foxo Technologies Inc   755.21 $ 0.145  Million 192 
Allogene Therapeutics Inc   625.00 $ 0.095  Million 152 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.